Tesofensine and weight loss.
Sommet
Agnès
A
Pathak
Atul
A
Montastruc
Jean-Louis
JL
D019440:Anti-Obesity Agents / Q000009:adverse effects* / Q000627:therapeutic use; D019086:Bridged Bicyclo Compounds, Heterocyclic / Q000009:adverse effects* / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000139:chemically induced*; D006801:Humans; D001523:Mental Disorders / Q000139:chemically induced*; D009765:Obesity / Q000188:drug therapy
D019440:Anti-Obesity Agents; D019086:Bridged Bicyclo Compounds, Heterocyclic; C518479:Tesofensine